Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment.
Kosydar SR, Parikh SA, Lester SC, Rabe KG, Ding W, Burlile JF, Kenderian SS, Wang Y, Muchtar E, Koehler AB, Schwager SM, Slager SL, Kay NE, Call TG, Breen WG, Hampel PJ.
Kosydar SR, et al.
Am J Hematol. 2023 Nov;98(11):E318-E321. doi: 10.1002/ajh.27060. Epub 2023 Aug 24.
Am J Hematol. 2023.
PMID: 37614209
Free article.
No abstract available.